Biblioteca Humberto Rosselli Quijano
Volver a la pantalla de resultados de la última búsqueda | Consultar el historial de búsquedas | New search |
Resultado de la búsqueda
1 búsqueda de la palabra clave 'Antipsicotico inyectable + placebo, Esquizofrenia.'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia / Fumiaki Kumagai en The Journal of Clinical Psychiatry, Año 2019 - Vol. 80 - No.1 (Enero - Febrero)
[artículo]
Título : Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia : Combined Analysis of 4 RCTs Tipo de documento: texto impreso Autores: Fumiaki Kumagai, Autor ; Takefumi Suzuki, Autor ; Wolfgang Fleischhacker, Autor Fecha de publicación: 2019 Artículo en la página: pp. 45-50 Idioma : Inglés (eng) Palabras clave: Antipsicotico inyectable + placebo, Esquizofrenia. Resumen: Placebo effects remain largely unexplored in clinical trials of long-acting injectable (LAI) antipsychotics for schizophrenia. This study aims to characterize patients showing improvements after placebo injections and to search for criteria for the prediction of subsequent response based on the magnitude of score changes after the first week of treatment. Link: ./index.php?lvl=notice_display&id=20477
in The Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.1 (Enero - Febrero) . - pp. 45-50[artículo] Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia : Combined Analysis of 4 RCTs [texto impreso] / Fumiaki Kumagai, Autor ; Takefumi Suzuki, Autor ; Wolfgang Fleischhacker, Autor . - 2019 . - pp. 45-50.
Idioma : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.1 (Enero - Febrero) . - pp. 45-50
Palabras clave: Antipsicotico inyectable + placebo, Esquizofrenia. Resumen: Placebo effects remain largely unexplored in clinical trials of long-acting injectable (LAI) antipsychotics for schizophrenia. This study aims to characterize patients showing improvements after placebo injections and to search for criteria for the prediction of subsequent response based on the magnitude of score changes after the first week of treatment. Link: ./index.php?lvl=notice_display&id=20477